4 Main Symptoms of Paget’s Disease of the Bone

Paget’s disease of the bone is often described as an uncommon condition, but that does not mean it is rare enough to ignore. In the United States alone, experts estimate that roughly 1% to 2% of adults over the age of 55 are affected, with the likelihood increasing as people get older. Many never realize they have it because the disease can develop slowly over several years. In fact, a significant number of cases are discovered by accident during imaging tests or blood work performed for an entirely different reason.

The condition changes the normal process of bone remodeling. Healthy bone is constantly being broken down and rebuilt in a carefully balanced cycle. With Paget’s disease, that balance is disrupted. Bones are broken down much faster than normal, forcing the body to rebuild them quickly. The new bone that forms is often larger, weaker, and less organized than healthy bone. Over time, this can increase the risk of pain, deformities, fractures, arthritis, and hearing problems, depending on which bones are involved.

One of the biggest challenges is that the early warning signs can be easy to dismiss. A lingering ache may be blamed on aging. Joint stiffness may seem like ordinary arthritis. Even changes in the shape of a limb or an increase in hat size can develop so gradually that they go unnoticed. By the time symptoms become obvious, the disease may have already caused significant changes to the affected bone.

Recognizing the symptoms early can make a meaningful difference. While there is no cure for Paget’s disease of the bone, treatments can help slow abnormal bone remodeling, reduce discomfort, and lower the risk of long-term complications. Below are four of the main symptoms of Paget’s disease of the bone, along with an explanation of why they occur and when they should prompt a conversation with a healthcare provider.

4 Main Signs and Symptoms of Paget’s Disease of the Bone

Bone Pain

Bone pain is the most common and frequently reported symptom of Paget’s Disease of Bone, affecting a majority of symptomatic patients. This pain is a direct consequence of the underlying pathological process. The accelerated and chaotic bone remodeling leads to increased metabolic activity and blood flow within the affected bone, which can cause a deep, persistent ache.

Unlike the pain from osteoarthritis, which is typically worse with activity and relieved by rest, Pagetic bone pain can be constant and may even worsen at night or during periods of rest. The character of the pain is often described as a dull, boring, or deep ache that is localized to the affected bone or region.

More specifically, the location of the pain corresponds directly to the bones involved in the disease process. Pain in the hip or groin area is common when the pelvis is affected. This can be mistaken for hip arthritis or bursitis, but the nature of the pain is often different. It can make activities like walking or standing for long periods difficult.

When Paget’s disease affects the spine, it can cause persistent back pain. This pain can radiate if the enlarged vertebrae begin to compress nearby nerve roots, a condition known as radiculopathy. Involvement of the thigh bone (femur) or shin bone (tibia) can cause aching pain in the legs. This pain can be diffuse and is often exacerbated by weight-bearing activities.

Though less common as a source of pain, skull involvement can lead to persistent headaches due to the increased blood flow and enlargement of the cranial bones. It is also important to differentiate the sources of pain in patients with Paget’s disease.

The pain can stem from the active disease process itself, from microfractures (tiny cracks) that develop in the weakened bone, or from secondary complications like osteoarthritis, which can develop in joints adjacent to Paget-affected bones due to altered biomechanics and bone deformities.

Bone Deformities

Paget’s Disease of the Bone can absolutely cause significant and sometimes disfiguring bone deformities. These structural changes are a direct result of the core pathology of the disease: the chaotic and uncontrolled bone remodeling process.

As osteoclasts aggressively break down bone and osteoblasts rush to replace it with disorganized, weaker woven bone, the affected bones can thicken, enlarge, and change shape over time. This new bone lacks the strong, organized lamellar structure of healthy bone, leading to both enlargement and a loss of mechanical integrity. The deformities are often slowly progressive and become more apparent as the disease advances, particularly if left untreated.

When weight-bearing long bones like the femur (thigh bone) or tibia (shin bone) are affected, they can weaken and gradually bend or bow under the body’s weight. This can result in a “bowlegged” (genu varum) or “knock-kneed” (genu valgum) appearance. This bowing not only alters a person’s appearance but also changes their gait and can place abnormal stress on nearby joints, such as the hips and knees, leading to secondary osteoarthritis.

If Paget’s disease affects the bones of the cranium, the skull can become progressively larger. Patients may report that their hat size has increased over time. A characteristic sign is “frontal bossing,” where the forehead becomes more prominent. This enlargement can also lead to a heavier-feeling head and may be associated with headaches.

When the vertebrae of the spine are affected, they can enlarge and weaken. This can lead to compression fractures or a gradual change in spinal alignment, resulting in an exaggerated forward rounding of the back, a condition known as kyphosis. This can cause chronic back pain, reduced height, and postural problems.

Other bones can also be affected. For example, an enlarged clavicle (collarbone) may become noticeable, or the jawbone (mandible) can enlarge, potentially leading to dental problems.

Fractures

Paget’s Disease of the Bone leads to fractures because the new bone created during the chaotic remodeling process is structurally disorganized, brittle, and significantly weaker than normal bone. Healthy bone has a highly organized, layered (lamellar) structure that gives it both strength and resilience.

In Paget’s disease, the frenzied activity of osteoblasts results in the rapid deposition of woven bone, which has a haphazard, mosaic-like pattern of collagen fibers. This disorganized architecture makes the bone more porous, less dense, and much more susceptible to breaking under stress that a healthy bone could easily withstand. The affected bone is often described as being like chalk—hard but brittle.

For example, the mechanism of fracture in Paget’s disease is multifaceted and includes several key factors. The primary reason is the inferior quality of the Pagetic bone. It lacks the ability to effectively distribute mechanical forces, making it prone to failure. This is why fractures can occur either spontaneously or as a result of very minor trauma that would not typically cause a break.

As discussed previously, deformities like the bowing of long bones (e.g., the femur) create points of high mechanical stress. The convex (outer) side of the bowed bone is under constant tension, making it a common site for incomplete “stress” or “fissure” fractures to develop. These small cracks can be a source of pain and, if left unmanaged, can progress to a complete fracture.

Pagetic bone is highly vascular, meaning it has an abnormally rich blood supply. While this might seem beneficial, it can further compromise the bone’s structural integrity. During surgical repair of a fracture, this increased vascularity can also lead to excessive bleeding, complicating the procedure.

A characteristic type of fracture seen in Paget’s disease is the chalkstick fracture. This is a complete, transverse fracture that occurs across the long axis of a bowed bone, typically the femur. The break is often clean and straight, similar to snapping a piece of chalk, which is a direct reflection of the bone’s brittleness. These fractures can be difficult to heal and often require surgical intervention, such as intramedullary nailing, to ensure proper alignment and stability.

Neurological Symptoms

The neurological symptoms associated with Paget’s Disease of the Bone are primarily caused by the overgrowth and enlargement of affected bones, which can compress or entrap nearby neural structures like the brain, spinal cord, or peripheral nerves.

As the Pagetic bone expands, it can narrow the foramina (openings) through which nerves exit the skull or spine, or it can directly impinge on the spinal cord itself. These symptoms are among the more serious complications of the disease and vary widely depending on the location of the affected bone.

More specifically, when the skull is affected, the enlarging bone can compress the cranial nerves. The most common neurological symptom of Paget’s disease is hearing loss. This can occur for several reasons: direct compression of the auditory nerve (cranial nerve VIII), damage to the tiny bones of the inner ear (cochlea), or encroachment on the structures of the middle ear.

Other less common cranial nerve issues can include vertigo, vision problems (if the optic nerve is compressed), or facial nerve palsy. Headaches are also a frequent complaint with skull involvement, caused by the increased vascularity and bony enlargement.

Enlargement of the vertebrae in the spine can lead to a narrowing of the spinal canal, a condition known as spinal stenosis. This can put pressure on the spinal cord itself, potentially leading to a serious condition called myelopathy, with symptoms like difficulty walking, balance problems, and bowel or bladder dysfunction.

More commonly, the vertebral overgrowth compresses the nerve roots as they exit the spinal column. This is called radiculopathy, and it causes symptoms such as pain, tingling, numbness, or weakness that radiates into the arms or legs, following the path of the affected nerve (e.g., sciatica).

While less common, Pagetic bone overgrowth in other areas can also entrap peripheral nerves. For example, enlargement of the pelvic bones could potentially compress nerves leading to the legs, causing symptoms similar to those of spinal nerve compression.

These neurological symptoms often develop gradually and require careful diagnosis through imaging studies like MRI or CT scans to visualize the extent of nerve compression. Treatment may involve medications to control the Pagetic process, and in severe cases, surgery may be necessary to decompress the affected nerves.

What is Paget’s Disease of the Bone?

Paget’s Disease of Bone is a chronic metabolic disorder that disrupts the normal cycle of bone renewal, causing bones to become enlarged, misshapen, and structurally weak. It is the second most common metabolic bone disease after osteoporosis.

The disease interferes with the body’s natural process of bone remodeling, a lifelong mechanism where old bone tissue is broken down (resorbed) and new bone tissue is formed in its place. In individuals with Paget’s disease, this process becomes disorganized and hyperactive in localized areas of the skeleton.

The result is a chaotic bone structure that is highly vascularized, less compact, more fragile, and more susceptible to complications such as pain, deformities, and fractures. The condition can affect a single bone (monostotic) or multiple bones (polyostotic), but it does not spread from one bone to another; the sites affected are typically established early in the disease course.

How Does Paget’s Disease Disrupt The Normal Bone Remodeling Process?

Paget’s Disease disrupts the normal bone remodeling process by creating an imbalance and acceleration in the activities of bone cells, specifically the osteoclasts (cells that break down bone) and osteoblasts (cells that build bone).

This disruption typically occurs in three distinct, though often overlapping, phases. The fundamental problem begins with the overactivity of osteoclasts, which triggers a cascade of chaotic cellular responses, ultimately leading to the formation of abnormal bone.

Phase 1: The Lytic Phase (Osteoclastic Activity):

This initial phase is characterized by a dramatic increase in the number and activity of osteoclasts. These cells, which are abnormally large and contain multiple nuclei in Paget’s disease, aggressively resorb bone at an accelerated rate. This intense bone breakdown creates lytic lesions or areas of reduced bone density, which can be seen on X-rays as V-shaped patterns (in long bones) or well-demarcated areas of radiolucency (in the skull, known as osteoporosis circumscripta).

Phase 2: The Mixed Phase (Lytic and Blastic Activity):

The body attempts to compensate for the excessive bone breakdown by rapidly forming new bone. In this phase, there is a surge in the activity of osteoblasts. However, the bone formation is frenzied and disorganized.

The osteoblasts lay down new bone collagen in a haphazard, woven pattern rather than the strong, layered (lamellar) structure of normal bone. This phase is characterized by a high rate of bone turnover, with both resorption and formation occurring simultaneously at an accelerated pace. The bone becomes highly vascular, with an increased number of blood vessels.

Phase 3: The Sclerotic Phase (Osteoblastic Activity):

Eventually, the process of bone formation begins to dominate over bone resorption. However, the bone that is formed remains structurally abnormal. This phase results in thickened, dense, and enlarged bone, which appears as sclerotic (abnormally hardened) on an X-ray.

Despite its dense appearance, this “Pagetic” or “mosaic” bone is mechanically weak, brittle, and prone to fractures and deformities. The normal, organized architecture is replaced by a chaotic pattern of cement lines that demarcate areas of poorly organized bone.

Affected Bones By This Condition

The bones most commonly affected by Paget’s Disease of Bone are those with high rates of blood flow and bone turnover, including the pelvis, spine, femur (thigh bone), skull, and tibia (shin bone). The disease typically presents in an asymmetric pattern, meaning it might affect the right femur but not the left.

While it can theoretically occur in any bone in the body, its predilection for these specific sites accounts for many of the classic signs and symptoms associated with the condition. The distribution is usually established early in the disease process and does not typically spread to new bones later in life.

Pelvis is the most frequently affected site, involved in over 70% of cases. Pelvic involvement is often asymptomatic but can cause hip pain, which may be mistaken for arthritis. The proximity to the hip joint means that deformities in the pelvic bone can alter joint mechanics and lead to secondary osteoarthritis.

The lumbar (lower back) and thoracic (mid-back) spine are common locations. Enlargement of the vertebrae can cause back pain, stiffness, and postural changes like kyphosis. More seriously, it can lead to the compression of spinal nerve roots or the spinal cord itself, resulting in neurological symptoms such as sciatica or spinal stenosis.

Also, the thigh bone is the most commonly affected long bone. Its involvement is particularly concerning because it is a major weight-bearing bone. The femur can become bowed, leading to gait abnormalities and stress on the knee and hip joints. It is also a common site for the characteristic “chalkstick” fractures.

When the skull is involved, it can lead to an increase in head size, frontal bossing, and headaches. The most significant complication is hearing loss, which occurs due to the compression of the auditory nerve or damage to the delicate structures of the inner ear.

The shin bone, another major weight-bearing bone in the leg, is also frequently affected. Similar to the femur, it is susceptible to bowing, which can alter alignment and increase the risk of pain and secondary arthritis in the knee and ankle.

Causes and Risk Factors for Paget’s Disease of the Bone

The primary causes of Paget’s Disease of Bone are not fully understood, but the main risk factors involve a strong genetic predisposition combined with certain environmental triggers and advancing age. The disease is considered multifactorial, meaning that no single cause has been identified.

Instead, current research points to a complex interplay between an individual’s genetic makeup and one or more external factors that may activate the disease process over time. The clustering of cases within families and in specific geographic regions strongly supports this gene-environment interaction model.

While the exact environmental trigger remains elusive, the genetic components are becoming increasingly clear, providing important clues about the underlying mechanisms of the disease. Understanding these risk factors is essential for identifying individuals who may be at higher risk and for guiding future research into prevention and treatment strategies.

Gene

In many cases, Paget’s Disease of Bone is considered a genetic condition, as a family history of the disease is one of the most significant risk factors for developing it. There is a clear hereditary component, with studies showing that up to 40% of patients with Paget’s disease have at least one first-degree relative (a parent, sibling, or child) who also has the condition.

This familial clustering suggests that inherited genetic mutations play a crucial role in predisposing an individual to the disease. The inheritance pattern in these families is typically autosomal dominant, meaning that a child of an affected parent has a 50% chance of inheriting the faulty gene.

The SQSTM1 gene provides instructions for making a protein that is involved in multiple cellular processes, including the regulation of inflammation and the lifecycle of osteoclasts, the cells responsible for bone resorption. Mutations in the SQSTM1 gene are found in a significant percentage of patients with familial Paget’s disease (up to 50%) and also in a smaller percentage of patients with sporadic (non-familial) cases.

The SQSTM1 protein is a key component of the RANK signaling pathway, which acts as a master regulator of osteoclast formation and activity. Mutations are believed to make this pathway hyper-responsive, leading to the formation of the abnormally large, numerous, and overactive osteoclasts that are the hallmark of Paget’s disease. This genetic susceptibility essentially primes the bone cells for the disordered remodeling process.

While SQSTM1 is the most prominent gene identified, research has uncovered other genetic loci and potential genes that may contribute to the risk of developing Paget’s disease. This indicates that the genetic basis of the disease is complex and likely involves multiple genes interacting with each other and with environmental factors. Identifying these genes helps scientists better understand the disease’s pathophysiology and develop more targeted therapies.

Age

The connection between age and the risk of developing Paget’s Disease of Bone is direct and significant; the prevalence of the disease increases substantially with advancing age. Paget’s disease is extremely rare in individuals under the age of 40. The incidence begins to rise after this point and becomes most common in people over the age of 55.

The prevalence can reach as high as 2-3% in the population over 55 and continues to increase in older age groups. This strong age-related correlation suggests that the disease may be the result of a long-latency process, where a combination of underlying genetic susceptibility and cumulative exposure to environmental factors over a lifetime is required to trigger the disease.

For example, one prominent theory proposes that a slow-acting virus, contracted early in life, may be the environmental trigger. The leading candidate for many years has been a virus from the paramyxovirus family, such as the measles virus or canine distemper virus.

According to this hypothesis, viral particles may lie dormant in bone cells for decades. In genetically susceptible individuals, these viral elements could later activate the abnormal osteoclast activity seen in Paget’s disease as the immune system changes with age. While viral genetic material has been found in Pagetic osteoclasts, a definitive causal link has not yet been proven.

Another possibility is that the process of aging itself contributes to the accumulation of somatic mutations (genetic alterations that are not inherited) in bone precursor cells. Over many years, these acquired mutations could potentially disrupt the normal regulation of bone remodeling, leading to the development of the disease in localized areas of the skeleton.

The link with age is also tied to geography and ancestry. The disease is most prevalent in populations of Anglo-Saxon descent, particularly in countries like the United Kingdom, Australia, New Zealand, and the United States. In contrast, it is rare in people from Asia and Africa. This geographical distribution, combined with the age factor, strongly supports the idea that migrating populations carried the predisposing genes with them, and the disease manifests later in life, possibly after exposure to localized environmental factors.

Potential Complications of Untreated Paget’s Disease of the Bone

Untreated or severe Paget’s disease can lead to a cascade of debilitating complications affecting not only the skeleton but other body systems as well. The abnormal bone structure, which is enlarged but weak, is prone to bowing and fractures, particularly in weight-bearing bones like the femur and tibia.

Within the joints, the distorted shape of Pagetic bone can accelerate wear and tear on cartilage, resulting in severe osteoarthritis. This is especially common in the hip and knee, causing chronic pain, stiffness, and reduced mobility that may ultimately require joint replacement surgery.

Systemically, the highly vascular nature of Pagetic bone demands a significantly increased blood supply. This can force the heart to pump harder to meet the demand, potentially leading to high-output heart failure in individuals with extensive disease. Metabolic complications can also arise, such as hypercalcemia (high blood calcium) if a patient is immobilized, which in turn increases the risk of developing painful kidney stones.

Though extremely rare, occurring in less than 1% of patients, the most serious complication is the malignant transformation of affected bone into Paget’s sarcoma, a highly aggressive form of bone cancer.

The Difference Between Paget’s Disease and Osteoporosis

While both Paget’s disease and osteoporosis affect bone health and increase fracture risk, they are fundamentally different conditions in their underlying pathology, presentation, and scope. The primary distinction lies in the nature of the bone remodeling process.

Paget’s disease is a localized disorder characterized by a chaotic and accelerated cycle of bone breakdown and formation. Overactive bone cells (osteoclasts and osteoblasts) lead to the creation of structurally disorganized, enlarged, and weakened bone in one or more specific areas of the skeleton.

In contrast, osteoporosis is a systemic disease affecting the entire skeleton. It is defined by a gradual loss of bone mass and mineral density, where the rate of bone resorption (breakdown) exceeds the rate of bone formation, leading to bones that are porous and brittle but not typically deformed. This core difference in pathology leads to distinct clinical features and diagnostic markers.

About pathophysiology, Paget’s disease involves a disorganized remodeling process with both excessive resorption and formation, creating structurally abnormal bone. Osteoporosis involves an imbalance where resorption outpaces formation, leading to a net loss of bone mass.

About scope, Paget’s disease is typically focal or multifocal, affecting specific bones like the pelvis, skull, spine, and long bones. Osteoporosis is a systemic condition that affects the entire skeleton uniformly.

In Paget’s, affected bones become enlarged, deformed, and architecturally unsound. In osteoporosis, bones become thinner and more porous without significant changes in their overall shape or size.

Furthermore, Paget’s disease is associated with a significantly elevated level of serum alkaline phosphatase (ALP), a marker of high bone turnover. While bone turnover markers may be slightly elevated in osteoporosis, they do not reach the high levels seen in active Paget’s disease.

Paget’s Disease of the Bone Management

The management of Paget’s disease of bone focuses on controlling the abnormal remodeling process to relieve symptoms, prevent progression, and reduce the risk of complications. Treatment is typically recommended for patients who are symptomatic (experiencing pain, nerve compression, or deformity) or for asymptomatic patients with the disease in high-risk locations like the skull or long bones.

The cornerstone of medical therapy is a class of drugs called bisphosphonates. These medications work by binding to the bone surface and inhibiting the activity of osteoclasts, the cells responsible for bone breakdown.

By slowing this excessive resorption, they interrupt the chaotic remodeling cycle, allowing for the formation of more normal, organized bone. Intravenous bisphosphonates like zoledronic acid are often preferred for their potency and long-lasting effects, capable of inducing remission for years with a single infusion. Oral bisphosphonates, such as alendronate or risedronate, are also effective options.

Beyond medication, a comprehensive management plan addresses symptoms and functional limitations. This multifaceted approach ensures both the underlying disease and its consequences are managed effectively. Supportive care strategies often include:

For bone pain directly caused by the disease activity or secondary osteoarthritis, over-the-counter analgesics like acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used.

Therapists can help improve muscle strength, joint mobility, and balance to reduce the risk of falls and fractures. They can also recommend assistive devices like canes or walkers to improve safety and independence.

Surgery may be necessary to address complications such as fractures, which require internal fixation; severe joint degeneration, which may necessitate a hip or knee replacement; or bone deformities that cause nerve compression, requiring a procedure to relieve the pressure.

Three Phases of Paget’s Disease of the Bone

The pathophysiology of Paget’s disease of bone is characterized by a distinct, cyclical process that unfolds at the cellular level in three sequential phases. These stages describe the fluctuating activity of bone-resorbing cells (osteoclasts) and bone-forming cells (osteoblasts) that results in the classic structural abnormalities of Pagetic bone.

The initial stage is the lytic phase, which is dominated by a dramatic increase in the number and activity of osteoclasts. These cells become frenzied, aggressively breaking down existing bone at an accelerated rate.

This intense resorption creates advancing wedge-shaped lesions or areas of demineralization visible on X-rays, leaving behind weakened bone. This phase is often responsible for the initial symptoms of bone pain and can increase the risk of pathological fractures. It is marked by a significant release of calcium from the bone into the bloodstream.

Following the initial destructive phase, the disease progresses into the mixed phase, where both bone resorption and formation occur simultaneously and chaotically. In response to the aggressive breakdown, the body attempts to repair the damage by rapidly recruiting osteoblasts to the site. However, this compensatory bone formation is disorganized and hurried.

The new bone matrix is laid down haphazardly, resulting in a mosaic-like pattern of woven bone rather than the strong, lamellar structure of normal bone. This phase is characterized by a very high rate of bone turnover, with both breakdown and buildup occurring at extreme levels, leading to the highly vascular, enlarged, and structurally unsound bone typical of the disease.

Finally, the disease may enter the sclerotic phase, also known as the “burned-out” phase. In this late stage, the rate of bone formation begins to overtake the rate of resorption. The osteoclastic activity subsides, but the overactive osteoblasts continue to lay down dense, disorganized bone. The resulting bone is heavily mineralized and appears very dense (sclerotic) on X-rays, but it remains brittle, architecturally weak, and prone to fracture and deformity.

FAQs

1. Is Paget disease painful?

It can be, but not everyone experiences pain. Some people have no symptoms at all and only learn they have Paget’s disease after routine blood tests or imaging. When pain does occur, it is often described as a deep, persistent ache in the affected bone.

It may worsen at night or after physical activity. If the disease leads to complications such as arthritis, nerve compression, or fractures, the discomfort can become more noticeable. Proper treatment often helps relieve pain and slow disease progression.

2. Who is most at risk for Paget’s disease?

Age is one of the strongest risk factors. Paget’s disease is most commonly diagnosed in adults over 55, and the risk continues to increase with advancing age. Having a close family member with the condition also raises the likelihood of developing it, suggesting that genetics play an important role. The disease is more frequently reported in people of European ancestry and is slightly more common in men than women.

3. What can be mistaken for Paget’s disease?

Several conditions share symptoms with Paget’s disease, making diagnosis challenging without medical testing. Osteoarthritis, osteoporosis, bone metastases from cancer, stress fractures, chronic back problems, and other metabolic bone disorders can all cause bone pain or structural changes.

Healthcare providers typically use a combination of medical history, physical examination, blood tests, X-rays, and sometimes bone scans to distinguish Paget’s disease from these conditions.

4. How long can you live with Paget disease?

Paget’s disease itself usually does not shorten life expectancy. Many people live normal, full lives, especially when the condition is diagnosed early and managed appropriately.

The focus of treatment is to reduce symptoms, prevent complications, and preserve mobility. Regular follow-up with a healthcare provider helps monitor disease activity and address any problems before they become more serious.

5. What celebrity has Paget’s disease?

Several public figures have reportedly been diagnosed with Paget’s disease of the bone, including the late actor Sir Anthony Hopkins, who has spoken publicly about living with the condition. While celebrity stories can help raise awareness, every person’s experience is different. Symptoms, disease severity, and treatment response vary widely from one individual to another.

6. What kind of doctor treats Paget’s disease?

Treatment often begins with a primary care physician, who may refer patients to a specialist for further evaluation. Depending on the symptoms and affected bones, care may involve an endocrinologist, a rheumatologist, or an orthopedic surgeon. In cases involving hearing loss, a neurologic complication, or skull involvement, other specialists such as an otolaryngologist or neurologist may also become part of the care team.

Conclusion

Paget’s disease of the bone often develops quietly, making it easy to overlook until complications begin to appear. Recognizing the main symptoms, including persistent bone pain, enlarged or misshapen bones, joint problems, and nerve-related symptoms, can lead to earlier diagnosis and more effective treatment.

Although the condition cannot be cured, today’s therapies can slow abnormal bone remodeling, ease symptoms, and help reduce the risk of fractures and other long-term complications. If you notice ongoing bone pain or unexplained changes in the shape or function of a bone, don’t ignore them. A timely medical evaluation can provide answers and help protect your bone health for years to come.

References

• AAOS – Paget’s Disease of Bone
• Mayo Foundation – Paget’s disease of bone
• NHS – Paget’s disease of bone
• Healthdirect Australia Limited – Paget’s disease of bone
• Cleveland Clinic – Paget’s Disease of the Bone (Osteitis Deformans)
• Harvard Health Publishing – Paget’s disease of bone
• Better Health Channel – Paget’s disease of bone
• Penn Medicine – Paget’s disease of the bone
• Paget’s Association – Support and guidance from the Paget’s Association’s Helpline
• UCLA Health – Paget’s Disease Is a Chronic Bone Disorder
• Stanford Health Care – Paget’s Disease of the Bone Symptoms